Insider Buy/Sell Ratio — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Technology
Buys563
Sells11644
Buy $$8.23B
Sell $$12.96B
Ratio1:1.58
% Change vs. Prior
Ratio -60.1%Value -36.8%
Healthcare
Buys601
Sells4868
Buy $$316.86M
Sell $$11.50B
Ratio1:36.28
% Change vs. Prior
Ratio -35.0%Value -23.9%
Consumer Cyclical
Buys234
Sells2130
Buy $$95.84M
Sell $$7.41B
Ratio1:77.31
% Change vs. Prior
Ratio -97.4%Value +81.1%
Energy
Buys252
Sells465
Buy $$69.48M
Sell $$4.54B
Ratio1:65.37
% Change vs. Prior
Ratio -33.1%Value -25.6%
Industrials
Buys405
Sells1925
Buy $$316.93M
Sell $$4.22B
Ratio1:13.33
% Change vs. Prior
Ratio +43.3%Value -37.0%
Financial Services
Buys1058
Sells2932
Buy $$627.67M
Sell $$3.78B
Ratio1:6.02
% Change vs. Prior
Ratio -25.6%Value -0.1%
Consumer Defensive
Buys149
Sells649
Buy $$68.75M
Sell $$2.91B
Ratio1:42.29
% Change vs. Prior
Ratio -65.7%Value +43.0%
Communication Services
Buys138
Sells933
Buy $$186.58M
Sell $$1.21B
Ratio1:6.46
% Change vs. Prior
Ratio +237.2%Value +11.5%
Basic Materials
Buys147
Sells220
Buy $$39.09M
Sell $$358.68M
Ratio1:9.18
% Change vs. Prior
Ratio +8.7%Value -64.6%
Real Estate
Buys192
Sells310
Buy $$32.45M
Sell $$214.10M
Ratio1:6.60
% Change vs. Prior
Ratio -49.7%Value -46.6%
Utilities
Buys59
Sells210
Buy $$28.04M
Sell $$172.70M
Ratio1:6.16
% Change vs. Prior
Ratio +1813.0%Value -97.0%
By Industry
Hardware, Equipment & Parts
Buys20
Sells1247
Buy $$7.98B
Sell $$882.74M
Ratio9.04:1
% Change vs. Prior
Ratio -73.7%Value -56.7%
Biotechnology
Buys386
Sells3018
Buy $$268.61M
Sell $$3.58B
Ratio1:13.33
% Change vs. Prior
Ratio -57.3%Value +55.7%
Medical - Instruments & Supplies
Buys18
Sells152
Buy $$1.65M
Sell $$3.84B
Ratio1:2322.67
% Change vs. Prior
Ratio -89.3%Value -50.1%
Software - Application
Buys328
Sells2244
Buy $$190.13M
Sell $$2.66B
Ratio1:14.00
% Change vs. Prior
Ratio -79.4%Value +30.3%
Software - Infrastructure
Buys49
Sells3569
Buy $$9.29M
Sell $$2.83B
Ratio1:304.16
% Change vs. Prior
Ratio -75.4%Value -43.9%
Computer Hardware
Buys0
Sells2129
Buy $$0.00
Sell $$2.72B
RatioAll Sells
% Change vs. Prior
Ratio -100.0%Value +79.1%
Specialty Retail
Buys70
Sells933
Buy $$25.83M
Sell $$2.59B
Ratio1:100.36
% Change vs. Prior
Ratio -90.0%Value +32.6%
Semiconductors
Buys120
Sells1459
Buy $$12.23M
Sell $$2.31B
Ratio1:189.19
% Change vs. Prior
Ratio +254.4%Value -2.4%
Oil & Gas Exploration & Production
Buys157
Sells101
Buy $$35.75M
Sell $$2.16B
Ratio1:60.37
% Change vs. Prior
Ratio +87.7%Value -39.9%
Medical - Healthcare Information Services
Buys11
Sells323
Buy $$1.26M
Sell $$2.10B
Ratio1:1662.47
% Change vs. Prior
Ratio -97.1%Value +16.4%
Leisure
Buys9
Sells112
Buy $$6.84M
Sell $$1.27B
Ratio1:185.97
Aerospace & Defense
Buys34
Sells533
Buy $$1.22M
Sell $$1.18B
Ratio1:967.96
% Change vs. Prior
Ratio -92.3%Value -5.8%
Beverages - Non-Alcoholic
Buys14
Sells35
Buy $$2.78M
Sell $$1.17B
Ratio1:419.19
Apparel - Footwear & Accessories
Buys3
Sells51
Buy $$229.14K
Sell $$1.12B
Ratio1:4889.60
Asset Management
Buys319
Sells215
Buy $$132.61M
Sell $$892.33M
Ratio1:6.73
Transactions (30874)
VERACYTE, INC. (VCYT)
EASTHAM KARIN — Director
Shares
529
Price
$53.55
Total Value
$28.33K
Shares Held After
15,097
% of Holdings
3.4%
VERACYTE, INC. (VCYT)
EASTHAM KARIN — Director
Shares
3,200
Price
$52.78
Total Value
$168.91K
Shares Held After
15,626
% of Holdings
17.0%
Total Return Securities Fund (SWZ)
SELL MORITZ A — Director
Shares
1,853
Price
$5.91
Total Value
$10.95K
Shares Held After
16,155
% of Holdings
11.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
660
Price
$548.90
Total Value
$362.28K
Shares Held After
18,876
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
115
Price
$547.81
Total Value
$63.00K
Shares Held After
19,536
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
265
Price
$547.37
Total Value
$145.05K
Shares Held After
19,651
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$545.19
Total Value
$21.81K
Shares Held After
19,916
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$543.53
Total Value
$21.74K
Shares Held After
19,956
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
192
Price
$541.88
Total Value
$104.04K
Shares Held After
19,996
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
865
Price
$541.06
Total Value
$468.02K
Shares Held After
20,188
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,978
Price
$540.22
Total Value
$1.61M
Shares Held After
21,053
% of Holdings
12.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,035
Price
$539.42
Total Value
$1.10M
Shares Held After
24,031
% of Holdings
7.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,440
Price
$538.31
Total Value
$775.16K
Shares Held After
26,066
% of Holdings
5.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
600
Price
$537.24
Total Value
$322.34K
Shares Held After
27,506
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
210
Price
$536.27
Total Value
$112.62K
Shares Held After
28,106
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
160
Price
$534.48
Total Value
$85.52K
Shares Held After
28,316
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$533.59
Total Value
$213.43K
Shares Held After
28,476
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$552.72
Total Value
$88.44K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$548.84
Total Value
$263.45K
Shares Held After
40,673
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$547.51
Total Value
$175.20K
Shares Held After
41,153
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$545.19
Total Value
$21.81K
Shares Held After
41,473
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$544.01
Total Value
$21.76K
Shares Held After
41,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
613
Price
$541.49
Total Value
$331.94K
Shares Held After
41,553
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,022
Price
$540.52
Total Value
$1.09M
Shares Held After
42,166
% of Holdings
4.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,793
Price
$539.62
Total Value
$1.51M
Shares Held After
44,188
% of Holdings
5.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,399
Price
$538.59
Total Value
$753.49K
Shares Held After
46,981
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
828
Price
$537.52
Total Value
$445.07K
Shares Held After
48,380
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
245
Price
$536.59
Total Value
$131.47K
Shares Held After
49,208
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$535.01
Total Value
$42.80K
Shares Held After
49,453
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$533.79
Total Value
$256.22K
Shares Held After
49,533
% of Holdings
1.0%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Bumpus Namandje — Director
Shares
3,963
Price
$3.18
Total Value
$12.60K
Shares Held After
127,632
% of Holdings
3.0%
Anterix Inc. (ATEX)
Lang Scott A. — Director
Shares
170
Price
$80.25
Total Value
$13.64K
Shares Held After
76,527
% of Holdings
0.2%
HERSHEY CO (HSY)
Shares
331
Price
$174.22
Total Value
$57.67K
Shares Held After
1,396,119
% of Holdings
0.0%
HERSHEY CO (HSY)
Shares
1,220
Price
$173.33
Total Value
$211.47K
Shares Held After
1,396,450
% of Holdings
0.1%
HERSHEY CO (HSY)
Shares
5,611
Price
$172.47
Total Value
$967.76K
Shares Held After
1,397,670
% of Holdings
0.4%
HERSHEY CO (HSY)
Shares
2,838
Price
$171.66
Total Value
$487.17K
Shares Held After
1,403,281
% of Holdings
0.2%
Xencor Inc (XNCR)
Feigal Ellen — Director
Shares
6,843
Price
$13.06
Total Value
$89.37K
Shares Held After
12,340
% of Holdings
35.7%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
3,000
Price
$6.35
Total Value
$19.05K
Shares Held After
700,000
% of Holdings
0.4%
Shares
44,400
Price
$18.52
Total Value
$822.29K
Shares Held After
120,846
% of Holdings
26.9%
Opera Ltd (OPRA)
Jacobsen Frode — Chief Financial Officer
Shares
44,400
Price
$18.52
Total Value
$822.29K
Shares Held After
43,325
% of Holdings
50.6%
Sleep Number Corp (SNBR)
MENDEZ ANGEL L — Director
Shares
3,020
Price
$0.22
Total Value
$665.91
Shares Held After
34,495
% of Holdings
8.1%
F&M BANK CORP (FMBM)
Willingham John A. — Director
Shares
77
Price
$36.10
Total Value
$2.78K
Shares Held After
21,018
% of Holdings
0.4%
F&M BANK CORP (FMBM)
WRAY PETER H — Director
Shares
171
Price
$36.10
Total Value
$6.17K
Shares Held After
7,745
% of Holdings
2.2%
Nkarta, Inc. (NKTX)
HASTINGS PAUL J — Director
Shares
1,776
Price
$2.71
Total Value
$4.81K
Shares Held After
390,247
% of Holdings
0.5%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Shields Matthew — EVP, Global Operations
Shares
9,989
Price
$32.19
Total Value
$321.55K
Shares Held After
0
% of Holdings
100.0%
Vericel Corp (VCEL)
Halpin Michael — Chief Operating Officer
Shares
10,000
Price
$40.24
Total Value
$402.40K
Shares Held After
16,248
% of Holdings
38.1%
Vericel Corp (VCEL)
Flynn Sean C. — Chief Legal Officer
Shares
15,000
Price
$40.21
Total Value
$603.15K
Shares Held After
1,647
% of Holdings
90.1%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
81,898
Price
$5.99
Total Value
$490.49K
Shares Held After
378,195
% of Holdings
17.8%
Sleep Number Corp (SNBR)
Hellfeld Samuel R — EVP Chief Legal & Risk Officer
Shares
7,964
Price
$0.31
Total Value
$2.47K
Shares Held After
0
% of Holdings
100.0%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
2,634
Price
$35.39
Total Value
$93.22K
Shares Held After
180,597
% of Holdings
1.4%
Showing 1601–1650 of 30874 transactions (page 33 of 618)